FMP
Jan 31, 2024 1:53 PM - Davit Kirakosyan
Image credit: FMP
Boston Scientific (NYSE:BSX) announced its fourth-quarter results, which were better than expected, leading to a 4% increase in its shares intra-day today.
The medical device company reported adjusted earnings per share (EPS) of 55 cents for the fourth quarter, up from 45 cents in the same period the previous year and surpassing the consensus estimate of 51 cents. Boston Scientific's net sales also saw a notable year-over-year increase of 15% to $3.73 billion, outperforming the projected $3.6 billion.
Looking to the upcoming first quarter, Boston Scientific expects an adjusted EPS of between 50 and 52 cents, compared to the consensus estimate of 52 cents.
For the entire year, the company is projecting an adjusted EPS to range from $2.23 to $2.27, compared to the analysts' estimate of $2.24.
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...
May 24, 2024 9:30 AM - Rajnish Katharotiya
Earnings call transcripts are invaluable resources for investors, analysts, and financial enthusiasts. They provide insights into a company's performance, strategy, and future outlook, making them essential for making informed investment decisions. With Financial Modeling Prep, Earnings Call Transcr...
May 27, 2024 3:30 PM - Rajnish Katharotiya
In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...